Identification of Agents That Ameliorate Hyperphosphatemia-Suppressed Myogenin Expression Involved in the Nrf2/p62 Pathway in C2C12 Skeletal Muscle Cells.

Shu-Man Hsieh Li, Shu-Ting Liu, Yung-Lung Chang, Gunng-Shinng Chen, Shih-Ming Huang

Open access · goldAbstract read

In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 80% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shu-Man Hsieh LiDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.

Shu-Ting LiuDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.

Yung-Lung ChangDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.ORCID 0000-0002-6988-4890

Gunng-Shinng ChenSchool of Dentistry, Department of Dentistry of Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.

Shih-Ming HuangDepartment of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.ORCID 0000-0001-9305-921X

National Defense Medical Center · TWTri-Service General Hospital · TW

Funding

Ministry of National Defense-Medical Affairs Bureau, Taiwan MND-MAB-109-084, MND-MAB-110-089, and MND-MAB-111-094 to S-M HuangMinistry of Science and Technology, Taiwan MOST-111-2320-B-016-012 to S-M Huang

6 · The paper itself

Abstract

Hyperphosphatemia can occur as a result of reduced phosphate (P

Indexed as

Hydrogen PeroxideNF-E2-Related Factor 2AnimalsAscorbic AcidDoxorubicinKelch-Like ECH-Associated Protein 1MiceMuscle Fibers, SkeletalMuscular AtrophyMyogeninOxidative StressSequestosome-1 ProteinSignal TransductionAscorbic AcidDoxorubicinHydrogen PeroxideKelch-Like ECH-Associated Protein 1MyogeninNF-E2-Related Factor 2Sequestosome-1 ProteinhyperphosphatemiaL-ascorbic acidmyogeninnuclear factor erythroid 2-related factor 2p62

Identifiers

PMID36499650

DOI10.3390/ijms232315324

PMCPMC9736935

OpenAlexW4311521434

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.